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Abstract
Background: Vaccination is an effective way to curtail the burden of COVID-19 in which success depends on a
high acceptance of the vaccine. However, addressing concerns among vaccine-hesitant individuals is essential to
avoid failure of the immunisation programme. This study sought to assess the concerns and acceptance rates
regarding the COVID-19 vaccine among Malaysians.
Methods: An online questionnaire was distributed to 1411 respondents via a snowball sampling method among
Malaysians aged 18 years and above.
Results: The majority of the respondents were young adults (40.7%), female (62.8%), Malay (63.8%), Muslim (72.3%),
married (52.9%), with tertiary education (86.8%) and without medical illness (85%). Social media (97.4%) was the
primary source of information regarding COVID-19. The overall acceptance rate was high (83.3%), with the lowest
rates among the elderly aged 60 years and above (63.4%) and pensioners (64.6%). Hesitance was caused by
concerns regarding side effects (95.8%), safety (84.7%), lack of information (80.9%), effectiveness (63.6%) and
religious (20.8%) and cultural factors related to the COVID-19 vaccine (6.8%). Respondents with diabetes mellitus
(24.7%) and hypercholesterolemia (23%) were more hesitant to accept the COVID-19 vaccine, at 16.1 and 15.8%,
respectively. Predictors of COVID-19 vaccine hesitance were age, religion, and current residence.
Conclusions: The results indicate a high rate of acceptance of the COVID-19 vaccine among Malaysians. Thus, the
Malaysian government and other related agencies should increase their campaign and prepare to implement the
COVID-19 mass immunisation programme among Malaysians. However, despite the high acceptance rate, it
remains important to address concerns among hesitant individuals by building trust in vaccine safety and
effectiveness through adequate information regarding the vaccine.
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Background
The COVID-19 pandemic caused by severe acute re-
spiratory syndrome coronavirus 2 (SARS-CoV-2) has
infected more than 108 million people in over 150
countries. In Malaysia, as of February 15, 2021, more
than 261,805 confirmed cases with 958 deaths had
been reported [1, 2]. The pandemic continues to
threaten the healthcare system with catastrophic
economic, education, and social consequences world-
wide [3, 4].
Currently, no curative treatment exists for COVID-19
infection [5–7]. Therefore, a safe and effective prophy-
lactic vaccine is urgently needed to contain the pan-
demic, which has had devastating medical, economic,
and social repercussions [8]. To date, several vaccines
have been developed and approved for emergency im-
munisation [9–11]. This has given a glimpse of hope for
preventing the spread of COVID-19 infection. Countries
and governments worldwide have spent billions of dol-
lars in preparing to immunise the population of their
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